| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |